CLINICAL_TRIALS
trial_result
· 2021-04-01
Clinical Trial Update: Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer [Phase 2]
Summary
Phase 2 clinical trial update for DP303c Injection in advanced or metastatic gastric cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN